United States Biotechnology & Medical Research

Cyteir Therapeutics Inc (CYT)

Track

Ticker: CYT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cyteir Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 20 Mar 2024
Value US$3,454,578.71 | Price 385.04 | Shares 68,993 (-10.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-25 2024-03-20 B Purchase
2.9
Leonard Braden Michael
Large shareholder
68,993 -10.7%
385.04
US$3,454,579 		68,993 -10.7% 385.04 US$3,454,579
2024-03-19 2024-03-18 B Purchase
2.9
Leonard Braden Michael
Large shareholder
15,156 -8.6%
239.54
US$2,323,494 		15,156 -8.6% 239.54 US$2,323,494
2023-07-20 2023-07-20 S Sale
2.3
Novo Holdings A/S
Large shareholder
98,789 -44.6%
50.13
US$2,903,237 		98,789 -44.6% 50.13 US$2,903,237
2023-07-20 2023-07-19 S Sale
2.3
Novo Holdings A/S
Large shareholder
1,900 -0.1%
2.76
US$5,247 		1,900 -0.1% 2.76 US$5,247
2023-07-18 2023-07-18 S Sale
2.3
Novo Holdings A/S
Large shareholder
6,500 -0.2%
2.76
US$17,923 		6,500 -0.2% 2.76 US$17,923
2023-07-18 2023-07-17 S Sale
2.3
Novo Holdings A/S
Large shareholder
21,100 -0.6%
2.75
US$58,000 		21,100 -0.6% 2.75 US$58,000
2023-07-18 2023-07-14 S Sale
2.3
Novo Holdings A/S
Large shareholder
11,000 -0.3%
2.74
US$30,102 		11,000 -0.3% 2.74 US$30,102
2023-07-14 2023-07-14 PrS Proposed sale
2.3
Novo Holdings A/S

10% Stockholder

Large shareholder
2,986,257
2.74
US$8,182,344 		2,986,257 2.74 US$8,182,344
2023-07-03 2023-06-30 S Sale
2.3
Novo Holdings A/S
Large shareholder
200,937 -5.2%
2.63
US$529,288 		200,937 -5.2% 2.63 US$529,288
2023-06-28 2023-06-28 PrS Proposed sale
Secrist John Paul

Officer

Officer
13,181
1.76
US$23,249 		13,181 1.76 US$23,249
2023-06-28 2023-06-27 S Sale
2.3
Novo Holdings A/S
Large shareholder
31,978 -0.8%
1.77
US$56,687 		31,978 -0.8% 1.77 US$56,687
2023-06-28 2023-06-26 S Sale
2.3
Novo Holdings A/S
Large shareholder
8,437 -0.2%
1.79
US$15,106 		8,437 -0.2% 1.79 US$15,106
2023-06-23 2023-06-23 S Sale
2.3
Novo Holdings A/S
Large shareholder
3,423 -0.1%
1.88
US$6,447 		3,423 -0.1% 1.88 US$6,447
2023-06-23 2023-06-22 S Sale
2.3
Novo Holdings A/S
Large shareholder
5,041 -0.1%
1.94
US$9,783 		5,041 -0.1% 1.94 US$9,783
2023-06-23 2023-06-21 S Sale
2.3
Novo Holdings A/S
Large shareholder
4,834 -0.1%
1.99
US$9,641 		4,834 -0.1% 1.99 US$9,641
2023-06-20 2023-06-20 S Sale
2.3
Novo Holdings A/S
Large shareholder
744 -0.0%
2.11
US$1,573 		744 -0.0% 2.11 US$1,573
2023-06-20 2023-06-16 S Sale
2.3
Novo Holdings A/S
Large shareholder
5,983 -0.2%
2.03
US$12,142 		5,983 -0.2% 2.03 US$12,142
2023-06-20 2023-06-15 S Sale
2.3
Novo Holdings A/S
Large shareholder
10,002 -0.3%
2.03
US$20,304 		10,002 -0.3% 2.03 US$20,304
2023-06-14 2023-06-14 S Sale
2.3
Novo Holdings A/S
Large shareholder
2,872 -0.1%
2.11
US$6,050 		2,872 -0.1% 2.11 US$6,050
2023-06-14 2023-06-13 S Sale
2.3
Novo Holdings A/S
Large shareholder
2,626 -0.1%
2.10
US$5,515 		2,626 -0.1% 2.10 US$5,515
2023-06-14 2023-06-12 S Sale
2.3
Novo Holdings A/S
Large shareholder
900 -0.0%
2.06
US$1,858 		900 -0.0% 2.06 US$1,858
2023-06-12 2023-06-12 PrS Proposed sale
2.3
Novo Holdings A/S

10% Stockholder

Large shareholder
355,128
2.16
US$767,076 		355,128 2.16 US$767,076
2022-12-08 2022-12-07 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
21,202 +15.9%
1.30
US$27,563 		21,202 +15.9% 1.30 US$27,563
2022-07-22 2022-07-20 S Sale
2.3
Novo Holdings A/S
Large shareholder
900,000 -18.6%
3.00
US$2,700,000 		900,000 -18.6% 3.00 US$2,700,000
2022-05-16 2022-05-12 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
743 +0.6%
1.61
US$1,196 		743 +0.6% 1.61 US$1,196
2022-05-12 2022-05-11 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
1,000 +0.8%
1.70
US$1,700 		1,000 +0.8% 1.70 US$1,700
2022-05-12 2022-05-10 B Purchase
1.3
THERO JOHN F
Non-Executive Director
10,000 +inf%
2.00
US$20,000 		10,000 +inf% 2.00 US$20,000
2022-05-12 2022-05-10 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
49,406 +60.1%
1.89
US$93,377 		49,406 +60.1% 1.89 US$93,377
2021-12-21 2021-12-17 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
200 +0.2%
9.88
US$1,976 		200 +0.2% 9.88 US$1,976
2021-12-15 2021-12-15 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
1,700 +2.1%
11.12
US$18,904 		1,700 +2.1% 11.12 US$18,904
2021-12-15 2021-12-15 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
2,000 +2.6%
10.47
US$20,940 		2,000 +2.6% 10.47 US$20,940
2021-06-24 2021-06-22 B Purchase
1.3
Naesens Janwillem
Non-Executive Director
277,777 +8.5%
18.00
US$4,999,986 		277,777 +8.5% 18.00 US$4,999,986
2021-06-24 2021-06-22 B Purchase
1.3
Droia Invest II SCSp
Large shareholder
277,777 +8.5%
18.00
US$4,999,986 		277,777 +8.5% 18.00 US$4,999,986
2021-06-23 2021-06-22 B Purchase
2.3
Novo Holdings A/S
Large shareholder
277,777 +6.1%
18.00
US$4,999,986 		277,777 +6.1% 18.00 US$4,999,986
Explore more

More insider trading research around Cyteir Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America